INDBInternet News Database 2.5 Updated 2 min ago · 315 sources Show or hide images Light or dark

EMA Upholds Refusals for Pediatric Pain Spray and NPC Drug

Save Like Comments Compare coverage

Summary

The CHMP has confirmed refusal of KemSu for pediatric acute pain and Meplyffa for Niemann-Pick disease type C after reexamination, citing efficacy concerns. Medscape News Europe

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    EMA Upholds Refusals for Pediatric Pain Spray and NPC Drug

    The CHMP has confirmed refusal of KemSu for pediatric acute pain and Meplyffa for Niemann-Pick disease type C after reexamination, citing efficacy concerns. Medscape News Europe

Comments

Comments need JavaScript.